These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9436766)

  • 1. Lack of correlation between vertical transmission of HIV-1 and maternal antibody titers against autologous virus in human monocyte-derived macrophages.
    Mabondzo A; Narwa R; Roques P; Gras GS; Hervé F; Parnet-Mathieu F; Lasfargues G; Courpotin C; Dormont D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):92-4. PubMed ID: 9436766
    [No Abstract]   [Full Text] [Related]  

  • 2. Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.
    Bongertz V; Costa CI; Veloso VG; Grinsztejn B; João Filho EC; Calvet G; Pilotto JH; Guimarães ML; Morgado MG
    Scand J Immunol; 2001 Mar; 53(3):302-9. PubMed ID: 11251889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
    Lathey JL; Tsou J; Brinker K; Hsia K; Meyer WA; Spector SA
    J Infect Dis; 1999 Aug; 180(2):344-50. PubMed ID: 10395848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study.
    Kamara P; Melendez-Guerrero L; Arroyo M; Weiss H; Jolly P
    Virol J; 2005 Feb; 2():15. PubMed ID: 15730556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
    Ruppach H; Nara P; Raudonat I; Elanjikal Z; Rübsamen-Waigmann H; Dietrich U
    J Virol; 2000 Jun; 74(12):5403-11. PubMed ID: 10823844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant-maternal HIV-specific immunoglobulin G1 antibody ratios as an indicator of vertical transmission.
    Madurai S; Moodley D; Coovadia HM; Gopaul W; Smith AN; York DF
    AIDS; 1997 Jul; 11(9):1191-3. PubMed ID: 9233473
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
    Permar SR; Fong Y; Vandergrift N; Fouda GG; Gilbert P; Parks R; Jaeger FH; Pollara J; Martelli A; Liebl BE; Lloyd K; Yates NL; Overman RG; Shen X; Whitaker K; Chen H; Pritchett J; Solomon E; Friberg E; Marshall DJ; Whitesides JF; Gurley TC; Von Holle T; Martinez DR; Cai F; Kumar A; Xia SM; Lu X; Louzao R; Wilkes S; Datta S; Sarzotti-Kelsoe M; Liao HX; Ferrari G; Alam SM; Montefiori DC; Denny TN; Moody MA; Tomaras GD; Gao F; Haynes BF
    J Clin Invest; 2015 Jul; 125(7):2702-6. PubMed ID: 26053661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization titres and vertical HIV-1 transmission.
    Bongertz V; Costa CI; Veloso VG; Grinsztejn B; Filho EC; Calvet G; Pilotto JH
    Scand J Immunol; 2002 Dec; 56(6):642-4. PubMed ID: 12472677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
    Scarlatti G; Leitner T; Hodara V; Halapi E; Rossi P; Albert J; Fenyö EM
    AIDS; 1993 Nov; 7 Suppl 2():S45-8. PubMed ID: 8161445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.
    Jenkins M; Landers D; Williams-Herman D; Wara D; Viscarello RR; Hammill HA; Kline MW; Shearer WT; Charlebois ED; Kohl S
    J Infect Dis; 1994 Aug; 170(2):308-12. PubMed ID: 8035015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing antibodies and complement-mediated, antibody-dependent enhancement (C'-ADE) of human immunodeficiency virus infection in its vertical transmission.
    Gras G; Beyssen V; Tranchot-Diallo J; Parnet-Mathieu F; Lasfargues G; Courpotin C; Dormont D
    Am J Reprod Immunol; 1998 Jun; 39(6):381-6. PubMed ID: 9645269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
    Kumar A; Smith CEP; Giorgi EE; Eudailey J; Martinez DR; Yusim K; Douglas AO; Stamper L; McGuire E; LaBranche CC; Montefiori DC; Fouda GG; Gao F; Permar SR
    PLoS Pathog; 2018 Apr; 14(4):e1006944. PubMed ID: 29672607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting perinatal human immunodeficiency virus infection by antibody patterns.
    Moodley D; Bobat RA; Coutsoudis A; Coovadia HM
    Pediatr Infect Dis J; 1995 Oct; 14(10):850-2. PubMed ID: 8584310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA viral load test for early diagnosis of vertical transmission of HIV-1 infection.
    Souza IE; Azevedo ML; Succi RC; Machado DM; Diaz RS
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):358-60. PubMed ID: 10836762
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
    Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.